Correlation between Initial and Early Follow-Up CT Perfusion Parameters with Endoscopic Tumor Response in Patients with Advanced Squamous Cell Carcinomas of the Oropharynx Treated with Organ-Preservation Therapy

References

1. ↵
   Calais G, Alfonsi M, Barbet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1994;886:265–72
2. ↵
   Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 2000;83:1594–98

   CrossRefPubMedWeb of Science
3. ↵
   Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991 ,324:1685–90

   PubMedWeb of Science
4. ↵
   Wolf GT, Bradford CR, Urba S, et al. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer. Laryngoscope 2002;112:1351–56

   CrossRefPubMed
5. ↵
   Cenic A, Nabavi DG, Craen RA, et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462–70

   Abstract/FREE Full Text
6. ↵
   Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. Semin Ultrasound CT MR 2000;21:462–77

   CrossRefPubMed
7. ↵
   Roberts HC, Roberts TP, Lee TY, et al. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases. AJNR Am J Neuroradiol 2002;23:828–32

   Abstract/FREE Full Text
8. ↵
   Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003;27:687–93

   CrossRefPubMed
9. ↵
   Schmitt P, Kotas M, Tobermann A, et al. Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother Oncol 2003;67:27–34

   CrossRefPubMed
10. ↵
    Ressel A, Weiss C, Feyerabend T. Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival. Int J Radiat Oncol Biol Phys 2001;49:1119–25

    PubMed
11. ↵
    Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–56

    CrossRefPubMedWeb of Science
12. ↵
    Fleiss JL, Kingman A. Statistical management of data in clinical research. Crit Rev Oral Biol Med 1990;1:55–66

    FREE Full Text
13. ↵
    Carlos RC, Stanley JC, Stafford-Johnson D, et al. Inter-observer variability in evaluating chronic mesenteric ischemia by gadolinium enhanced MR angiography. Acad Rad 2001;8:835–44
14. ↵
    Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000;57:39–43

    CrossRefPubMedWeb of Science
15. ↵
    Goda F, Bacic G, O’Hara JA, et al. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res 1996;56:3344–49

    Abstract/FREE Full Text
16. ↵
    Groshar D, McEwan AJ, Parliament MB, et al. Imaging tumor hypoxia and tumor perfusion. J Nucl Med 1993;34:885–88

    Abstract/FREE Full Text
17. ↵
    Robinson SP, Collingridge DR, Howe FA, et al. Tumor response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98–106

    CrossRefPubMedWeb of Science
18. ↵
    Hoskin PJ, Saunders MI, Goodchild K, et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999;72:1093–98

    Abstract
19. ↵
    Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598–602

    Abstract/FREE Full Text
20. ↵
    Cenic A, Nabavi DG, Craen R, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63–73

    Abstract/FREE Full Text
21. ↵
    Wintermark M, Thiran JP, Maeder P, et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001;22:905–14

    Abstract/FREE Full Text
22. ↵
    Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol 1999;30:198–205

    CrossRefPubMedWeb of Science
23. ↵
    Robbins KT, Storniolo AM, Kerber C, et al. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–71

    PubMed
24. ↵
    Robbins KT, Fontanesi J, Wong FS, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Head Neck 1996;122:853–57
25. ↵
    Zatterstrom UK, Brun E, Willen R, et al. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995;17:312–18

    PubMedWeb of Science
26. ↵
    Carrau RL, Barnes EL, Snyderman CH, et al. Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck. Invasion Metastasis 1995;15:197–202

    PubMedWeb of Science
27. ↵
    Miller KD, Sweeney CJ, Sledge GW Jr. Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 2001;19:1195–206

    Abstract/FREE Full Text
28. ↵
    Kumar P, Benedict R, Urzua F, et al. Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest 2005;85:756–67

    CrossRefPubMed
29. ↵
    Lennernas B, Albertsson P, Lennernas H, et al. Chemotherapy and antiangiogenesis: drug-specific, dose-related effects. Acta Oncol 2003;42:294–303

    CrossRefPubMed
30. ↵
    Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189–200

    Abstract/FREE Full Text
31. ↵
    Rezai A, Gandhi D, Mukherji SK. CT perfusion studies of the neck, ICA versus ECA as the input artery. Presented at: American Society of Head and Neck Radiology Meeting, Rancho Mirage, Calif, October 2,2003 (abstract 6)